APPLICATION
ANDA208600
TYPE
ANDA
ORIGINAL APPROVAL
2019-03-14
LATEST ACTION
2022-11-15
ROUTE
INTRAVENOUS, SUBCUTANEOUS, INTRAVENOUS, SUBCUTANEOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
ENOXAPARIN SODIUMPrescription
ENOXAPARIN SODIUM 300MG/3ML (100MG/ML) · INJECTABLE · INTRAVENOUS, SUBCUTANEOUS
Approval history
2022-11-15Labeling · Supplement 2 · standardAP
2019-03-14UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.